Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Br J Hosp Med (Lond)
; 82(3): 1-9, 2021 Mar 02.
Article
in English
| MEDLINE | ID: covidwho-1168180
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and socioeconomic consequences worldwide. Researchers have raced to understand the pathophysiological mechanisms underpinning the disease caused by SARS-CoV-2 so that effective therapeutic targets can be discovered. This review summarises the key pharmacotherapies that are being investigated for treatment of COVID-19, including antiviral, immunomodulator and anticoagulation strategies.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Platelet Aggregation Inhibitors
/
COVID-19 Drug Treatment
/
Glucocorticoids
/
Immunologic Factors
/
Anticoagulants
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Br J Hosp Med (Lond)
Journal subject:
Hospitals
/
Medicine
Year:
2021
Document Type:
Article
Affiliation country:
Hmed.2021.0112
Similar
MEDLINE
...
LILACS
LIS